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Abstract
Background: Malaria is a risk factor for invasive non-typhoidal Salmonella (NTS) infection in children. In the last 10 years,
indices of malaria infection in The Gambia have fallen substantially.
Methods: We compared temporal trends of childhood malaria and NTS infection in two Gambian locations. In Fajara, on the
coast, the incidence of NTS infection at three time points between 1979 and 2005 was compared to the percentage of
malaria positive outpatient thick blood films and the percentage of admissions associated with malaria over time. In Basse,
in the eastern part of the country, the incidence of NTS infection at three time points between 1989 and 2008 was
compared to the prevalence of malaria parasitaemia at four time points between 1992 and 2008.
Results: The estimated incidence of NTS infection in Fajara fell from 60 (1979–1984) to 10 (2003–05) cases per 100,000
person years. The proportion of outpatients in Fajara with suspected malaria who were parasitaemic fell from 33% (1999) to
6% (2007) while the proportion of admissions associated with malaria fell from 14.5% (1999) to 5% (2007). In Basse, the
estimated incidence of NTS infection fell from 105 (1989–1991) to 29 (2008) cases per 100,000 person years while the
prevalence of malaria parasitaemia fell from 45% (1992) to 10% (2008). The incidence of pneumococcal bacteraemia in
Fajara and Basse did not fall over the study period.
Conclusions: These data support an association between malaria and NTS infection. Reductions in malaria infection may be
associated with reduced rates of invasive childhood NTS infection.
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Introduction
Non-typhoidal Salmonella species (NTS) are a leading cause of
invasivebacterial infection in African children and are responsible for
many deaths [1,2]. Invasive NTS infection is difficult to manage, and
is often complicated by resistance to commonly used antibiotics [3].
Evidence suggests that malaria is a risk factor for invasive NTS
infection in children. In regions of seasonal malaria transmission,
annual peaks of NTS and malaria infection coincide [4–7]. Invasive
NTS is frequently associated with recent [5] or concurrent malaria
infection [4,7,8], particularly severe malarial anemia [1,4,7,9,10].
Over the last 10 years, indices of malaria infection in The Gambia
have fallen substantially [11]. If malaria is a risk factor for NTS
infection, it would be anticipated that a fall in malaria incidence would
be associated with reduced rates of NTS infection. To investigate this
hypothesis we reviewed data on malaria and NTS infection in two
regions of The Gambia collected during the past 30 years.
Methods
We reviewed data from studies conducted in two locations in
The Gambia, Fajara and Basse. The Gambian climate is sub-
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most malaria transmission occurs. Almost all cases of malaria are
due to Plasmodium falciparum. The Medical Research Council
(MRC) Laboratories in Fajara, on the Atlantic coast, have
provided clinical services for the surrounding population since
the late 1950s. Basse is situated in the rural eastern part of the
country about 400 km from the coast, where MRC has conducted
studies since 1982.
To relate indices of invasive NTS and malaria infection in
Fajara, four data sets were used (tables 1 and 2). These were (a)
blood cultures taken for clinical purposes from all unwell children
under 5 years of age admitted to the MRC hospital in Fajara
between 1979 and 1984 [4], (b) blood cultures obtained from
children aged 2–35 months with suspected meningitis, sepsis or
pneumonia during a large-scale trial of Haemophilus influenzae type b
(Hib) conjugate vaccine conducted in Western Region of The
Gambia from 1991 till 1995 [12], (c) blood cultures collected for
clinical purposes from all unwell patients aged less than 5 years
admitted to the MRC hospital between 2003 and 2005 [13], and
(d) routine malaria blood films obtained from patients who
presented as outpatients at the MRC hospital with fever or other
symptoms associated with malaria and also hospital admission
records throughout the observation period [11].
Manual blood culture methods were used in the first two
studies, after which an automated system was used. Salmonella typhi
and non-typhi isolates were differentiated in the two hospital-based
studies but not during the vaccine trial. However, S. typhi infections
are very uncommon in young children in The Gambia [13,14].
Thick blood films were read by experienced technicians and
examination was undertaken on 100 high-power fields (1000 times
magnification) for each slide throughout the observation period.
To determine the approximate incidence of blood culture
positive NTS and invasive pneumococcal disease (IPD), an
estimate was made of the catchment population for the MRC
Hospital during the 1979-84 study (100000 with 20% aged less
than 5 years). Population growth of 3% per year was used to give
an estimated population for the 2003–2005 study. Because
children in the Hib vaccine trial were aged 2 to 35 months, the
overall incidence of IPD in children aged less than 5 years during
the vaccine trial was estimated based on reported age-specific rates
of IPD. Age-specific rates of IPD and NTS infection were
extrapolated using data from two Kenyan studies which
documented that the incidence of invasive IPD and NTS among
children aged 36-59 months was approximately half the incidence
among those aged 24–35 months [2,5]. The population aged 3
and 4 years during the Hib trial (and the pneumococcal vaccine
trial in Basse) was assumed to be the same as the population aged 2
years. Age-specific rates of NTS infection during the Hib vaccine
trial are unavailable, however the total number of Salmonella
isolates is known. The incidence of NTS infection in the trial was
extrapolated by multiplying the incidence of IPD by the ratio of
NTS to pneumococcal isolates detected in blood.
Three studies in Basse have documented the incidence of
invasive NTS and IPD (tables 1 and 3): (a) community-based
surveillance of children for suspected pneumonia, meningitis or
septicemia between 1989 and 1991 [6,15], (b) surveillance during
a 9-valent pneumococcal conjugate vaccine trial undertaken
between 2000 and 2004 – only findings from children in the
placebo group are used in this analysis [14,16], and (c) ongoing
surveillance for invasive bacterial infections which began in 2008.
Methods of case ascertainment were comparable in these three
studies (blood cultures were performed for all children with clinical
pneumonia or symptoms or signs suggestive of sepsis or meningitis,
table 1). Automated blood cultures were performed in the second
and third studies and traditional microbiological methods for
identification of NTS were used in all three studies.
During the 1989–91 study, the under-5 population of Upper
River Region (URR) was estimated to be 24793 and approxi-
mately half the population lived in areas covered by the disease
surveillance [15]. The person-years at risk in the placebo group of
Table 1. Characteristics of studies included in the analysis.
Ref. Location Year Population Design Laboratory method Outcome
[4] Fajara 1979–84 Admissions ,5 years of age Observational Conventional blood culture Incidence NTS and IPD
[12] Western 1993–95 Out/inpatients 2–35 months of age RCT Conventional blood culture Incidence NTS and IPD
[13] Fajara 2003–05 Admissions ,5 years of age Observational Automated blood culture Incidence NTS and IPD
* Fajara 1982 & 1994 Outpatients Observational Positive malaria slide Percentage slides
positive
[11] Fajara 1999–2007 Outpatients/inpatients Observational Positive malaria slide Percentage slides
positive
Percentage malaria
admissions
[6,15] URR 1989–91 Outpatients ,5 years of age Observational Conventional blood culture Incidence NTS and IPD
[14,16] U/CRR 2000–04 Out/inpatients 2–29 months of age RCT Automated blood culture Incidence NTS and IPD
* URR 2008 Out/inpatients ,5 years of age Observational Automated blood culture Incidence NTS and IPD
[17] URR 1992 Community ,5 years of age Survey Positive malaria slide Prevalence malaria
parasitaemia
* URR 1994 Clinical trial 15–20 months of age Survey Positive malaria slide Prevalence malaria
parasitaemia
[18] URR 1995 Clinical trial 27–32 months of age Survey Positive malaria slide Prevalence malaria
parasitaemia
[19] URR 2008 Community ,5 years of age Survey Positive malaria slide Prevalence malaria
parasitaemia
Note: * authors’ unpublished data. URR, Upper River Region. CRR, Central River Region.
doi:10.1371/journal.pone.0010568.t001
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participants assigned to vaccine. In 2008, a demographic survey
showed that the under-5 population was 24480. The age range of
children included in the pneumococcal vaccine trial was 6 weeks to
29 months. The estimated incidence of invasive infection among
those aged 36–59 months during the vaccine trial was assumed to
be half of that among those aged 24–29 months [2,5]. Universal
pneumococcal vaccination was not introduced during the
observation period.
Three studies in Basse documented the prevalence of malaria
parasitaemia in children aged less than 5 years during the study
period (tables 1 and 3): (a) a population-based survey conducted in
1992 as part of an evaluation of insecticide treated bed nets [17],
(b) surveys undertaken among children aged 15–20 months in
1994 and 23–28 months in 1995 as part of a malaria vaccine trial
[18], and (c) a population-based survey undertaken in 2008 [19].
Case ascertainment was comparable in these studies, each survey
being conducted at the end of the wet season with similar
microscopic techniques.
We compared temporal patterns of NTS infection with indices
of malaria infection at the closest time point for which malaria
data were available. To provide a prevalence measure of NTS
infection relative to other pathogens, and for partial control of
confounding due to variable blood culture practices and age, we
calculated the ratio of NTS to pneumococcal (P) isolates detected
in blood cultures in all the studies (NTS:P). We also compared
trends in the incidence of blood culture positive IPD with the
incidence of NTS infection in children less than 5 years of age in
all the studies.
At the end of 2004, the government guideline for first-line
therapy of mild malaria was changed from chloroquine to a
combination of chloroquine, sulfadoxine and pyrimethamine.
Artemether plus lumefantrine was introduced through government
health facilities in 2008. Quinine was the treatment of choice for
severe malaria throughout the observation period. Multiple
indicator surveys in 2000 and 2006 documented the proportion
of children under 5 years of age sleeping under insecticide treated
nets as 14.5% and 49% respectively [20,21].
Data were extracted directly from publications and derived
from current studies. Incidence rates were calculated assuming
Poisson distributions.
All the clinical trials from which data presented in this paper
have been derived were approved by the Gambia Government/
MRC Joint Ethics Committee and all research study participants
provided written informed consent.
Results
Fajara
Over a 69 month period from 1979 until 1984, pathogenic
bacteria were isolated from 259 patients less than 5 years of age
(approximately 20000 population and 115000 person-years at
risk) who presented to the MRC Hospital, Fajara; 69 were NTS
and 38 were pneumococci (NTS:P=1.8) [4] (Table 2). During
32 months of a Hib conjugate vaccine trial (1993–95), 2408
blood cultures were taken and 39 Salmonella spp.a n d7 6
pneumococci were isolated from blood (NTS:P=0.51) [12].
During 16 months from 2003 until 2005, 871 blood cultures
were taken from children under 5 years (approximately 38322
population and 51096 person-years at risk) who presented at the
MRC Hospital; 93 pathogens were isolated, 5 NTS and 29
pneumococci (NTS:P=0.17) [13]. Over the study period, the
incidence of NTS infection among those less than 5 years fell by
84% (95% CI: 60, 95), from approximately 60 to 10 cases per
100000 person-years (figure 1). The estimated incidence of IPD
did not fall over this time, with point estimates of 33, 70 and 57
cases per 100000 person-years in the three studies (table 2 &
figure 1).
The fall in invasive NTS infection followed a similar pattern to
the fall in malaria infection (table 2 & figure 1). The proportion of
admissions attributed to malaria fell over a period of 6 years, from
20.5% in 2001 to 5% in 2007 [11]. The percentage of positive
malaria slides in outpatients was stable between 1979 and 2001, at
around 20% to 30% (authors’ unpublished data [BG]); this then
fell over a period of 9 years, from 33% in 1999 to 6% in 2007
(figure 1).
Table 2. Data derived from Fajara, Western Region studies.
Ref. Location Year
Population &
(person-years)
denominators
NTS
isolates
Pneumococcal
isolates
NTS incidence
,5 years*
IPD incidence
,5 years*
Percentage
malaria slides
positive
Percentage
malaria
admissions
[4] Fajara 1979–84 20000 (115000) 69 38 60 33 n/a n/a
[12] Western 1993–95 (64181, 0–3 years) 39{ 76{ 361 70I n/a n/a
[13] Fajara 2003–05 38322 (51096) 5 29 10 57 n/a n/a
{ Fajara 1982
1994
n/a n/a n/a n/a n/a 22%
32%
[11] Fajara 1999
2001
2003
2005
2007
n/a n/a n/a n/a n/a 33%
32%
22%
8%
6%
14.5%
20.5%
17%
8.5%
5%
Note: * Incidence per 100000 person-years.
{Authors’ unpublished data (BG).
{76/116 (66%) pneumococcal isolates were from blood cultures.
1As estimates of age-specific NTS infection are not available, the incidence of NTS disease is estimated from the ratio of NTS to pneumococcal isolates, 39:76=0.51, and
the estimated incidence of pneumococcal blood stream infection.
IIncidence of pneumococcal blood stream infection is calculated from values reported by Usen et al. 1998 [12] and the proportion of IPD due to blood stream infection
(0.66), as 0–1 yr: 17860.66=117, 2 yrs: 8660.66=57, 3–4 yrs: extrapolated as half the incidence among those 2 yrs of age; 57/2=29, ,5 yrs: [(11762)+57+(2962)]/
5=70. 1 Incidence of NTS disease is calculated as 7060.51=36.
doi:10.1371/journal.pone.0010568.t002
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Twenty-four months of community-based surveillance for invasive
bacterial infection under 5 years of age was conducted between 1989
and 1991 (24793 person-years at risk)[15] (Table 3).Twenty-six NTS
and 46 pneumococci were isolated (NTS:P=0.57, figure 2). From
2000 until 2004, during a pneumococcal conjugate vaccine trial, 49
NTS and 59 pneumococci were isolated from blood in separate
episodes in the placebo group (NTS:P=0.83) [14,16]. During 12
months of surveillance in 2008 (24480 person-years at risk), 7 NTS
and 36 pneumococci were isolated from children under 5 years of age
(NTS:P=0.19) (authors’ unpublished data [GM]). The incidence of
invasive NTS among those less than 5 years fell by 73% (95% CI: 37,
88) over the period of the three studies, from 105 to 29 cases per
100000 person-years (figure 2). The incidence of IPD in non-
vaccinated children remained stable with point estimates of 186, 225
and 147 cases per 100000 person-years respectively (figure 2).
The end of transmission season prevalence of malaria parasites
in cross-sectional surveys of young children resident in URR fell
from 45% (1992), 39% (1994) and 35% (1995) to 10% in 2008
(figure 2) [17–19].
Table 3. Data derived from Basse, Upper River Region studies.
Ref. Location Year
Population & (person-
years) denominators
NTS
isolates
Pneumococcal
isolates
NTS incidence
,5 years*
IPD incidence
,5 years*
Prevalence
malaria
parasitaemia
[6,15] URR 1989–91 12396 (24793) 26 46 105 186 n/a
[14,16] U/CRR 2000–04 (16501, 0–2.5 years){ 49{ 601 156I 225** n/a
{{ URR 2008 24480 (24480) 7 36 29 147 n/a
[17] URR 1992 n/a n/a n/a n/a n/a 44.7%
{{ URR 1994 n/a n/a n/a n/a n/a 39%
[18] URR 1995 n/a n/a n/a n/a n/a 35%
[19] URR 2008 n/a n/a n/a n/a n/a 9.5%
Note: * Incidence per 100000 person-years. UUR, Upper River Region. CRR, Central River Region.
{Person-years at risk in the placebo group is calculated from Enwere et al. (2006) in which there were 330 episodes of invasive bacterial infection in vaccine and placebo
groups with overall incidence of 1009 per 100000 person-years [14]; 0.56(330/1009610
25)=16501 person-years.
{The number of NTS isolates in the placebo group is calculated using the ratio of NTS incidence in placebo (300610
25) versus vaccine (262610
25) groups=1.14 [14],
and given 92 NTS isolates were detected in both groups. Thus, there were 49 NTS isolates in the placebo group (49/43=1.14 and 49+43=92).
1The number of pneumococcal isolates in the placebo group is calculated using the incidence of IPD in placebo (453610
25) versus vaccine (256610
25) groups=1.77
[14], and given 94 pneumococcal bloodstream isolates were detected in both groups. Thus, there were 60 pneumococcal isolates in the placebo group (60/34=1.77
and 60+34=94).
INTS incidence calculated using age-specific incidence from Enwere et al., i.e. 2–5 mo: 408, 6–11 mo: 360, 12–17 mo: 334, 18–23 mo: 293, 24–29 mo: 42, 3–4 years:
extrapolated as half the incidence among those 2 years of age, 42/2=21, ,5 years: [(408/2)+(360/2)+(334/2)+(293/2)+42+21+21]/5=156.
**IPD incidence calculated from age-specific values [14], 2–5 mo: 363, 6–11 mo: 576, 12–17 mo: 526, 18–23 mo: 351, 24–29 mo: 339, 3–4 yrs: extrapolated as 339/
2=170. Calculation of ,5 years incidence of IPD takes into account that 71% of pneumococcal isolates were derived from blood [14]: 0.71[(363/2)+(576/2)+(526/
2)+(351/2)+339+170+170]/5=225.
{{authors’ unpublished data.
doi:10.1371/journal.pone.0010568.t003
Figure 1. Fajara: Temporal trends of non-typhoid salmonella and pneumococcal bacteraemia, and malaria indices.
doi:10.1371/journal.pone.0010568.g001
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As far as we are aware, this is the first report to document
reduced rates of invasive NTS infection in children associated with
reductions in malaria.
The time point at which the incidence of NTS infection in
Fajara began to fall is uncertain, but it is somewhere between 1994
and 2004 (figure 1). Malaria infection in Fajara began to fall
around 2001, and markedly so in 2003 [11]. Thus, the decline in
the incidence of NTS followed a comparable time course to the fall
in malaria. In Basse, the incidence of NTS infection fell between
2002 and 2008 (figure 2), showing a similar temporal pattern to
the recent decline of malaria in The Gambia [11].
This study has several weaknesses inherent in a retrospective
analysis of data collected for other purposes. Temporal changes in
disease would have been best described by continuous data
collection. At Basse, blood cultures were collected from children
identified in populations under surveillance whilst at Fajara
samples were obtained from children who came from a wide area
and chose the MRC hospital as their centre for care. Thus, the
Basse data are more representative of the population than those of
Fajara, but the similar patterns of falling malaria and NTS
infection in both locations strengthen the case for an association
between malaria and invasive NTS infection. We made intuitive
assumptions on the catchment populations for the MRC Hospital
at Fajara, and so these incidence estimates are only approximate.
Calculation of disease incidence assumed similar under-5 age
structure in the Hib and pneumococcal vaccine trials as in the
other studies providing data. Likewise, the association of NTS and
IPD with age strata less than 5 years was assumed to be the same
for both organisms. If these assumptions are false, the interpre-
tation of the data would not change but be strengthened as the
true difference between the incidence of IPD and NTS in the latter
studies would be greater than that which was observed.
There were differences in selection criteria for blood culture in
the Fajara studies, where blood cultures may have been collected
more assiduously during the vaccine trial than during routine
hospital admissions. However, the comparability between NTS
studies conducted in Basse should be good as similar criteria for
blood cultures were used in the three studies. To reduce
confounding by variable patient selection or factors reducing the
risk of any bacteraemia, we calculated rates of pneumococcal
blood stream infections during the same surveillance periods.
Greatly reduced NTS:P ratios of blood culture isolates suggests
that there has been a marked decline in the prevalence of NTS
infection which is not due to changes in selection criteria for blood
culture nor due to non-species specific reductions in rates of
childhood bacteraemia. Although automated blood culture
systems were introduced during the study period this is unlikely
to have changed the sensitivity of NTS detection. Methods for
calculation of malaria admissions and slide positivity in Fajara
were consistent throughout as were the population-based malaria
prevalence survey techniques used in Basse. Unfortunately, we do
not have detailed information on the age distribution of children
under the age of 5 years admitted to the hospital in Fajara and
changes in this pattern could have influenced the apparent decline
in the prevalence of malaria. However, experience of those
involved in patient care at the MRC hospital indicates that if there
has been a change in age pattern this has been small. As malaria
prevalence estimates from Basse were derived from population-
based surveys less than 5 years of age, these data are not subject to
bias due to changes in age. The similar pattern and magnitude of
NTS reduction in parallel with reduced malaria prevalence in
Fajara and Basse suggests that the age-related bias in the Fajara
data is not substantial. Therefore, our interpretation of a potential
association between reduced prevalence of childhood malaria and
reduced incidence of NTS infection remains valid.
A decline in the incidence of NTS infection in parallel with a
decline in malaria does not prove cause and effect and we have
considered other possible explanations for our findings. Improved
socio-economic and environmental conditions may be associated
with reduced risk of childhood malaria and enteric infections
associated with fecal-oral transmission, and hence reduced rates of
NTS infection. One study has documented reduced rates of
diarrhoea in The Gambia between 1979 and 1993 [22]. This
study however, predates the observed reductions in malaria (from
Figure 2. Basse: Temporal trends of non-typhoid salmonella and pneumococcal bacteraemia, and malaria prevalence.
doi:10.1371/journal.pone.0010568.g002
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and 2002–2008 in Basse [figures 1 and 2]). Furthermore,
gastrointestinal infection remains prevalent in URR with 25% of
carers in a 2008 survey reporting recent diarrhea among children
less than 5 years of age (authors’ unpublished data [DS]). Rainfall
may relate to both the intensity of malaria transmission and risk of
NTS infection. The annual rainfall in the Greater Banjul area has
fluctuated between approximately 1100 millimeters in 1999 and
850 millimeters in 2007 [11]. Annual rainfall in Basse from 1998
until 2008 remained stable at between 700 millimeters and 1000
millimeters. Use of trimethoprim-sulphamethoxazole for commu-
nity-based pneumonia management may have influenced rates of
NTS and malaria infection although resistance of NTS to this drug
is significant in Fajara [13] and Basse. Likewise, sulfadoxine has
antibacterial activity and it was widely used in combination
therapy for uncomplicated malaria and combination sulfadoxine
and pyrimethamine remains the mainstay of malaria intermittent
preventive therapy. HIV and malnutrition are risk factors for NTS
infection. HIV prevalence has remained less than 2% in The
Gambia during the past 20 years, and Multiple Indicator Cluster
Surveys in 1996, 2000 and 2005/6 do not suggest substantial
changes in patterns of malnutrition [20,21,23]. Although some of
the competing explanations for our findings may have influenced
NTS and malaria infection to some degree, it seems the dramatic
fall in incidence of malaria in the Gambia is the most likely reason
why the incidence of NTS infection has fallen so markedly.
Previous epidemiological, clinical and pathophysiological stud-
ies support our hypothesis that the reduction in NTS infection
which has been observed in The Gambia is likely to be associated
with the substantial fall in malaria which has been recently
observed in the country. Compared to other forms of bacteraemia,
invasive NTS has previously been associated with anaemia [4,5,7–
10], splenomegaly [5,7–9], recent [5] and concurrent malaria
parasitaemia [4,7–10]. The link between NTS and anaemia
suggests a possible mechanism for the observed association
between the decline in the incidence of NTS and the decline in
the incidence of malaria in The Gambia as a reduced rate of
anaemia has been observed in The Gambia in association with the
reduction in malaria [11]. A further epidemiological factor which
may contribute to reduced NTS infection is the increase in median
age of children with malaria in The Gambia [11] as infants and
young children are at the greatest risk of NTS infection. Possibly
the strongest epidemiological evidence linking reductions of NTS
and malaria are the elegant descriptions from The Gambia [4,6]
and Kenya [5] illustrating the intimate relationship between
seasonal changes in the incidence of malaria and NTS infection
while the prevalence of NTS in stool was relatively stable
throughout the year [4,5]. A number of ways in which malaria
might reduce host defenses against invasive NTS infection have
been suggested [1]. These include: altered humoral immunity and
antibody response to Salmonella antigens, increased circulating
immune complexes which inhibit Fc receptor-mediated phagocy-
tosis, reduced complement levels, alteration of phagocytic and
bactericidal function by ingested malaria pigment, altered splenic
function, free haemoglobin resulting in production of methaem-
albumin and increased availability of iron stimulating bacterial
growth through the many iron uptake pathways possessed by
NTS.
An intervention study in The Gambia has shown that the use of
insecticide treated bed nets was associated with reductions in
overall child mortality of a magnitude greater than what was
expected due to reductions in malaria-attributable child mortality
alone [24]. Furthermore, there has recently been a dramatic
decline in child mortality in The Gambia which has paralleled the
decline in the incidence of malaria (personal communication, M
Jasseh, 14 December 2009). This reduction is far greater than
would have been anticipated on the basis of the proportion of
deaths previously attributed directly to malaria. Similar changes
have been observed on the coast of Kenya, where the incidence of
NTS infections has also declined in parallel with marked
reductions in malaria transmission (personal communication, K
Marsh, 2 November 2009). One possible explanation for the
greater than expected impact of effective malaria control on
overall mortality in children living in malaria endemic areas is the
prevention of invasive infections by some bacterial species, as
suggested in the current study.
If similar findings to ours are found in other locations which
have experienced reductions in the incidence of malaria, the
implications are substantial. Investments in research and public
health to control malaria may have added value, reducing rates of
NTS infection and the associated child mortality, in addition to
reducing mortality related directly to malaria.
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